Lrig1: A new master regulator of epithelial stem cells

EMBO Journal

Volumn 31, Issue 9, 2012, Pages 2064-2066

  Ordóez Morán, Paloma ^a   Huelsken, Joerg ^a  

^a EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BROXURIDINE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; GEFITINIB; LEUCINE; MEMBRANE PROTEIN; MYC PROTEIN; NOTCH RECEPTOR; PROTEIN LEUCINE RICH REPEAT AND IG LIKE DOMAIN 1; SONIC HEDGEHOG PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; COLORECTAL CANCER; ENTERITIS; HAIR FOLLICLE; HOMEOSTASIS; HUMAN; INTESTINE EPITHELIUM CELL; MESENCHYME CELL; NONHUMAN; ONCOGENE C MYC; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STEM CELL; STEM CELL EXPANSION;

ANIMALS; EPITHELIAL CELLS; GLYCOPROTEINS; HUMANS; INTESTINE, SMALL; MEMBRANE GLYCOPROTEINS; MICE; ONCOGENE PROTEINS V-ERBB; STEM CELLS;

ERINACEIDAE;

EID: 84860507194     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.1038/emboj.2012.73     Document Type: Article

References (10)

1. Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, Santoro A, Bets D, Mueser M, Harstrick A, Verslype C, Chau I, Van Cutsem E (2004) Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 51: 337-345 (Pubitemid 38944402)
2. Egger B, Procaccino F, Lakshmanan J, Reinshagen M, Hoffmann P, Patel A, Reuben W, Gnanakkan S, Liu L, Barajas L, Eysselein VE (1997) Mice lacking transforming growth factor alpha have an increased susceptibility to dextran sulfate-induced colitis. Gastroenterology 113: 825-832 (Pubitemid 27381142)
3. Gumienny TL, Macneil L, Zimmerman CM, Wang H, Chin L, Wrana JL, Padgett RW (2010) Caenorhabditiselegans SMA-10/LRIG is a conserved transmembrane protein that enhances bone morphogenetic protein signaling. Plos Genet 6: e1000963
4. Hedman H, Henriksson R (2007) LRIG inhibitors of growth factor signalling-double-edged swords in human cancer? Eur J Cancer 43: 676-682 (Pubitemid 46502902)
5. Scoville DH, Sato T, He XC, Li L (2008) Current view: intestinal stem cells and signalling. Gastroenterology 134: 849-864 (Pubitemid 351312767)
6. Takeda N, Jain R, LeBoeuf MR, Wang Q, Lu MM, Epstein JA (2011) Interconversion between intestinal stem cell populations in distinct niches. Science 334: 1420-1424
7. Tian H, Biehs B, Warming S, Leong KG, Rangell L, Klein OD, de Sauvage FJ (2008) A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable. Nature 478: 255-259
8. Troyer KL, Luetteke NC, Saxon ML, Qiu TH, Xian CJ, Lee DC (2001) Growth retardation, duodenal lesions, and aberrant ileum architecture in triple null mice lacking EGF, amphiregulin, and TGFalpha. Gastroenterology 121: 68-78 (Pubitemid 32591516)
9. Watt FM, Jensen KB (2009) Epidermal stem cell diversity and quiescence. EMBO Mol Med 1: 260-267
10. Wong VW, Stange DE, Page ME, Buczacki S, Wabik A, Itami S, van deWetering M, Poulsom R,Wright NA, Trotter MW,Watt FM, Winton DJ, Clevers H, Jensen KB (2012) Lrig1 controls intestinal stem-cell homeostasis by negative regulation of ErbB signalling. Nat Cell Biol 14: 401-408